ArthroCare Stock Price, News & Analysis (NASDAQ:ARTC)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About ArthroCare (NASDAQ:ARTC)

ArthroCare logoArthroCare Corporation (ArthroCare) is a medical device company. ArthroCare develops and manufactures surgical devices, instruments, and implants. Its devices enable surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its Coblation technology. This technology dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology, including its OPUS line of fixation products, as well as re-usable surgical instruments. ArthroCare's two core product consists of sports medicine and ear, nose, and throat (ENT), as well as other areas, such as spine, wound care, urology and gynecology. It's Sports Medicine, ENT and other products are marketed and sold through two principal geographic distribution channels: Americas (North and South America) and International (all other geographies). In May 2014, Smith & Nephew PLC acquired the Company.

Receive ARTC News and Ratings via Email

Sign-up to receive the latest news and ratings for ARTC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryHealth Care Equipment


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

ArthroCare (NASDAQ:ARTC) Frequently Asked Questions

What is ArthroCare's stock symbol?

ArthroCare trades on the NASDAQ under the ticker symbol "ARTC."

Who are some of ArthroCare's key competitors?

Who are ArthroCare's key executives?

ArthroCare's management team includes the folowing people:

  • Gayle Wiley, Chief Human Resource Officer, Senior Vice President
  • Jean A. Woloszko M.D., Ph.D., Senior Vice President - Research and Development, Chief Technology Officer (Age 56)
  • Richard W. Rew II, Senior Vice President, General Counsel, Secretary (Age 49)
  • Scott Schaffner, Senior Vice President, General Manager - Sports Medicine (Age 44)
  • Fred B. Dinger III, Senior Vice President, General Manager of ENT
  • James L. Pacek, Senior Vice President - Global Markets and Sales Operations (Age 65)
  • Bruce C. Prothro, Chief Regulatory Officer, Senior Vice President - Quality Systems and Assurance (Age 52)
  • Fabiana Lacerca-Allen, Independent Director (Age 47)

Has ArthroCare been receiving favorable news coverage?

Media coverage about ARTC stock has trended positive this week, Accern Sentiment reports. The research group identifies positive and negative press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. ArthroCare earned a media sentiment score of 0.39 on Accern's scale. They also assigned media headlines about the medical device company an impact score of 45.19 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future.

How do I buy shares of ArthroCare?

Shares of ARTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact ArthroCare?

ArthroCare's mailing address is 7000 W William Cannon Dr, AUSTIN, TX 78735-8509, United States. The medical device company can be reached via phone at +1-512-3913900.

MarketBeat Community Rating for ArthroCare (ARTC)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  100 (Vote Outperform)
Underperform Votes:  86 (Vote Underperform)
Total Votes:  186
MarketBeat's community ratings are surveys of what our community members think about ArthroCare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

ArthroCare (NASDAQ:ARTC) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyN/AN/A
Consensus Rating Score: 3.003.00N/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

ArthroCare (NASDAQ:ARTC) Consensus Price Target History

Price Target History for ArthroCare (NASDAQ:ARTC)

ArthroCare (NASDAQ:ARTC) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/22/2018Chardan CapitalInitiated CoverageBuyLowView Rating Details
(Data available from 3/21/2016 forward)


ArthroCare (NASDAQ:ARTC) Earnings History and Estimates Chart

Earnings by Quarter for ArthroCare (NASDAQ:ARTC)

ArthroCare (NASDAQ ARTC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2014Q313$0.35$0.32$96.00 million$96.06 millionViewN/AView Earnings Details
2/13/2014Q213$0.40$0.30$100.53 million$101.70 millionViewN/AView Earnings Details
10/29/2013Q3 2013$0.29$0.27$89.46 million$91.86 millionViewN/AView Earnings Details
8/5/2013Q2 2013$0.34($0.27)$93.67 million$92.10 millionViewListenView Earnings Details
5/7/2013Q1 2013$0.37$0.30$94.41 million$92.30 millionViewListenView Earnings Details
2/13/2013Q4 2012$0.37$0.30$93.78 million$96.90 millionViewListenView Earnings Details
10/31/2012$0.28$0.27ViewN/AView Earnings Details
8/1/2012$0.37$0.34ViewN/AView Earnings Details
5/2/2012$0.34$0.36ViewN/AView Earnings Details
2/16/2012$0.41($1.06)ViewN/AView Earnings Details
11/2/2011$0.30$0.05ViewN/AView Earnings Details
8/3/2011$0.35$0.34ViewN/AView Earnings Details
5/2/2011$0.30$0.36ViewN/AView Earnings Details
2/14/2011$0.28$0.30ViewN/AView Earnings Details
11/1/2010Q3 2010$0.19$0.25ViewN/AView Earnings Details
8/3/2010Q2 2010$0.19$0.22ViewN/AView Earnings Details
5/5/2010Q1 2010$0.13$0.24ViewN/AView Earnings Details
3/15/2010Q4 2009($0.08)$0.21ViewN/AView Earnings Details
11/18/2009Q4 2008($0.35)ViewN/AView Earnings Details
4/21/2008Q1 2008$0.32$0.34ViewN/AView Earnings Details
2/19/2008Q4 2007$0.49$0.50ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


ArthroCare (NASDAQ:ARTC) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for ArthroCare (NASDAQ:ARTC)

No dividend announcements for this company have been tracked by

Insider Trades

ArthroCare (NASDAQ ARTC) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for ArthroCare (NASDAQ:ARTC)

ArthroCare (NASDAQ ARTC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/9/2014Jean WoloszkoSVPSell32,627$45.67$1,490,075.0940,511View SEC Filing  
1/8/2014Barbara BoyanDirectorSell10,000$45.00$450,000.0024,525View SEC Filing  
1/8/2014Bruce ProthroSVPSell33,478$45.82$1,533,961.9639,421View SEC Filing  
1/6/2014Bruce ProthroSVPSell6,167$39.75$245,138.2539,421View SEC Filing  
12/19/2013Barbara BoyanDirectorSell10,000$40.00$400,000.0024,525View SEC Filing  
12/19/2013Jean WoloszkoSVPSell10,657$39.98$426,066.8646,193View SEC Filing  
10/30/2013Jean WoloszkoSVPSell1,342$37.95$50,928.90View SEC Filing  
10/7/2013James PacekSVPSell2,500$34.48$86,200.0024,379View SEC Filing  
6/18/2013Bruce ProthroSVPSell2,512$36.00$90,432.00View SEC Filing  
5/24/2013Peter WilsonDirectorSell10,000$33.36$333,600.00View SEC Filing  
11/13/2012David FitzgeraldDirectorSell25,000$31.34$783,500.00View SEC Filing  
8/7/2012James G FosterDirectorSell35,000$28.81$1,008,350.00View SEC Filing  
(Data available from 1/1/2013 forward)


ArthroCare (NASDAQ ARTC) News Headlines

Contrasting ArthroCare (ARTC) & Quidel (QDEL)Contrasting ArthroCare (ARTC) & Quidel (QDEL) - February 7 at 11:44 PM

SEC Filings

ArthroCare (NASDAQ:ARTC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


ArthroCare (NASDAQ:ARTC) Income Statement, Balance Sheet and Cash Flow Statement


ArthroCare (NASDAQ ARTC) Stock Chart for Wednesday, March, 21, 2018

Loading chart…

This page was last updated on 3/21/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.